The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virusRobert Flisiak, Piétro Scalfaro, Józef Higersberger et al.|Hepatology|2008Cited by 223
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding AgentRoger G. Ptak, Brigitte Rosenwirth, Philippe Gallay et al.|Antimicrobial Agents and Chemotherapy|2008Cited by 115
Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey CellsUdayan Chatterji, Philippe Gallay, Michael Bobardt et al.|Journal of Biological Chemistry|2005Cited by 71
Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid PolymorphismsPhilippe Gallay, Brigitte Rosenwirth, Roger G. Ptak et al.|Viruses|2013Cited by 15